# IRDI SORIDEC Gestion

> IRDI SORIDEC Gestion is a VC fund backing Software and Biotechnology. See 54 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Toulouse, France
- Total investments: 54
- Last investment: Jun 2026
- Lead investor: 24%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/irdi-soridec-gestion/
- X (Twitter): https://twitter.com/IrdiCapital__I/
- Website: https://www.irdi.fr

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

## Contacts

5 contacts available for IRDI SORIDEC Gestion. Shizune tracks 1 team members at IRDI SORIDEC Gestion. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/irdi-soridec-gestion?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.6M–$5.8M |
| Series A | $3.7M–$13M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 11 | 20% |
| Biotechnology | 10 | 19% |
| Medical | 7 | 13% |
| Health Care | 7 | 13% |
| Manufacturing | 7 | 13% |

71 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 17 | 31% |
| Series A | 13 | 24% |
| Funding Round | 8 | 15% |
| Venture - Series Unknown | 5 | 9% |
| Series B | 4 | 7% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 40 | 74% |
| Brazil | 1 | 2% |
| Singapore | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Benedikt Timmerman | Venture Partner | 1 | https://shizune.co/investors/profile/benedikt-timmerman |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nepting | NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ... |  | Private Equity | Jun 11, 2026 |  |
| Donecle | Donecle offers an ultra-fast inspection solution based on drones. | $11.8M | Venture - Series Unknown | Apr 15, 2026 |  |
| DiappyMed | DiappyMed specializes in developing platforms to calculate insulin dosages. | $5.8M | Seed | Mar 22, 2026 |  |
| Sim&Cure | Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provideessential information prior to the choice of sizing. | $11.6M | Series A | Nov 28, 2025 |  |
| Infinite Orbits | Infinite Orbits is a satellite servicing company that focuses on satellite maintenance, orbit correction, and de-orbiting services. | $46.2M | Series B | Nov 10, 2025 |  |
| Greenphage | Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions tosupport its phage therapy efforts. | $2.2M | Seed | Jul 10, 2025 |  |
| bYoRNA | bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally. | $1.8M | Pre-Seed | Jul 08, 2025 |  |
| FEEDAE | Feedae uses AI-augmented dialog analysis to boost sales and customer service teams' performance. | $1.7M | Seed | Mar 31, 2025 |  |
| Matchers | Matchers specialize in providing organization training courses and programs related to administration and management. | $1.3M | Venture - Series Unknown | Dec 19, 2024 |  |
| Keysom | Develops RISC V based processor architectures that are automatically built from the application source code and dynamically reconfigurable. | $4.4M | Seed | Oct 08, 2024 |  |

10 of 54 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 15 deals together
- [Sofilaro](https://shizune.co/investors/profile/sofilaro) — VC Fund, 8 deals together
- [IXO Private Equity](https://shizune.co/investors/profile/ixo-private-equity) — VC Fund, 6 deals together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 5 deals together
- [European Innovation Council and SMEs Executive Agency](https://shizune.co/investors/profile/european-innovation-council-and-smes-executive-agency) — VC Fund, 4 deals together
- [M Capital Partners](https://shizune.co/investors/profile/m-capital-partners) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Climate Investors in France](https://shizune.co/investors/climate-investors-france)
- [Climate VC Funds in France](https://shizune.co/investors/climate-vc-funds-france)
- [Health Care Investors in France](https://shizune.co/investors/health-care-investors-france)
- [Health Care VC Funds in France](https://shizune.co/investors/health-care-vc-funds-france)
- [Manufacturing Investors in France](https://shizune.co/investors/manufacturing-investors-france)
- [Manufacturing VC Funds in France](https://shizune.co/investors/manufacturing-vc-funds-france)

## FAQ

### What does IRDI SORIDEC Gestion invest in?

IRDI SORIDEC Gestion invests primarily in Software, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 54 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is IRDI SORIDEC Gestion's check size?

IRDI SORIDEC Gestion typically joins rounds of $1.6M–$5.8M at Seed and $3.7M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IRDI SORIDEC Gestion participates in.

### How do I contact IRDI SORIDEC Gestion?

Public channels for IRDI SORIDEC Gestion include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at IRDI SORIDEC Gestion?

The team at IRDI SORIDEC Gestion includes Benedikt Timmerman (Venture Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co